A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer
出版年份 2013 全文链接
标题
A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer
作者
关键词
-
出版物
ONCOGENE
Volume 32, Issue 47, Pages 5377-5387
出版商
Springer Nature
发表日期
2013-08-12
DOI
10.1038/onc.2013.311
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer
- (2013) Luc Friboulet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploring biomarkers in head and neck cancer
- (2012) Corey J. Langer CANCER
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells
- (2012) H. Cheng et al. CARCINOGENESIS
- Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
- (2012) Ilirjana Bajrami et al. EMBO Molecular Medicine
- 348 Stability of PARP Inhibition by BMN 673 in Human PBMCs (and Leukaemic Cell Cultures)
- (2012) M.J. Patterson et al. EUROPEAN JOURNAL OF CANCER
- Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
- (2012) D Ross Camidge et al. LANCET ONCOLOGY
- Increased PARP-1 Association with DNA in Alkylation Damaged, PARP-Inhibited Mouse Fibroblasts
- (2012) P. S. Kedar et al. MOLECULAR CANCER RESEARCH
- Abstract A121: Novel PARP inhibitors with potent antitumor activity as single-agent and combination therapies
- (2012) B. Wang et al. MOLECULAR CANCER THERAPEUTICS
- The potential of exploiting DNA-repair defects for optimizing lung cancer treatment
- (2012) Sophie Postel-Vinay et al. Nature Reviews Clinical Oncology
- Structural Basis for DNA Damage-Dependent Poly(ADP-ribosyl)ation by Human PARP-1
- (2012) M.-F. Langelier et al. SCIENCE
- Preliminary indication of survival benefit fromERCC1andRRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: Evidence from an individual patient analysis
- (2011) George R. Simon et al. CANCER
- ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-analysis
- (2011) Ming Yin et al. CLINICAL CANCER RESEARCH
- Regulation of endonuclease activity in human nucleotide excision repair
- (2011) Adebanke F. Fagbemi et al. DNA REPAIR
- Crystal Structures of Poly(ADP-ribose) Polymerase-1 (PARP-1) Zinc Fingers Bound to DNA
- (2011) Marie-France Langelier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition
- (2011) Neil Johnson et al. NATURE MEDICINE
- Biomarker studies: a call for a comprehensive biomarker study registry
- (2011) Fabrice Andre et al. Nature Reviews Clinical Oncology
- Poly(ADP-ribose) polymerase and XPF–ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells
- (2011) Yong-Wei Zhang et al. NUCLEIC ACIDS RESEARCH
- ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial
- (2010) A. C. Vilmar et al. ANNALS OF ONCOLOGY
- A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
- (2010) M. Graeser et al. CLINICAL CANCER RESEARCH
- ERCC1: impact in multimodality treatment of upper gastrointestinal cancer
- (2010) Ralf Metzger et al. Future Oncology
- The Relationship of Platinum Resistance and ERCC1 Protein Expression in Epithelial Ovarian Cancer
- (2010) Karina Dahl Steffensen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis
- (2010) Sufeng Chen et al. LUNG CANCER
- Synthetic lethal approaches to breast cancer therapy
- (2010) Farah L. Rehman et al. Nature Reviews Clinical Oncology
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Impacts of ERCC1 Gene Exon VIII Alternative Splicing on Cisplatin-Resistance in Ovarian Cancer Cells
- (2009) Yehong Sun et al. CANCER INVESTIGATION
- RNA interference screening demystified
- (2009) C J Lord et al. JOURNAL OF CLINICAL PATHOLOGY
- A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor
- (2008) Nicholas C Turner et al. EMBO JOURNAL
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
- Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
- (2008) Daniel T. Bergstralh et al. TRENDS IN GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started